This video showcases a shoulder-length ash blonde lob styled into a sleek glass hair finish with a flawless blunt silhouette. The precision styling enhances the cool pearl tones while creating ...

The controversial new stained-glass windows for Paris' Notre-Dame Cathedral will soon be unveiled to the public. Designed by French artist Claire Tabouret, the six contemporary windows will replace ...

U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing ...

DIYer and woodworker April Wilkerson takes you step-by-step through the process of constructing a stunning, custom glass water feature designed to bring tranquility to your outdoor living space.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Imported generic drugs could face tariffs of up to 100% beginning in 2028 under a plan announced Tuesday by President Trump, who said the measure is intended to push manufacturers to move production ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Imported generic drugs will face a 100 percent tariff beginning in August 2028 unless manufacturers move production to the U.S., President Trump said in a social media post Tuesday. Trump wrote on ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. prescriptions—won’t stay in the clear for long. In ...

Trump has spent much of his presidency using the threat of levies to extract concessions from the pharmaceutical industry. Makers of brand-name medicines have rushed to announce U.S. investment deals ...